Troy E. Wilson - 02 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jan 2026, 16:31:04 UTC
Prior SEC filing
14 Nov 2025
Next SEC filing
26 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson

Key filing fact

Troy E. Wilson filed Form 4 for Kura Oncology, Inc. (KURA) on 06 Jan 2026.

Key facts

  • This page summarizes Troy E. Wilson's Form 4 filing for Kura Oncology, Inc. (KURA).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 06 Jan 2026, 16:31.

Change

  • Previous filing in this sequence was filed on 14 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001589597 Primary reporting owner

WILSON TROY EDWARD

Relationship
President and CEO, Director
Address
C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO
Signature
Teresa Bair, Attorney-in-fact for Troy E. Wilson
Signature date
06 Jan 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KURA transaction Derivative

Option to purchase common stock

Award

Transaction value
$0
Shares
+1,120,000
Change %
Price
$0.000000
Shares after
1,120,000
Date
02 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,120,000
Exercise price
$10.34
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option vests in 48 equal monthly installments commencing on the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .